Expressing thiopurine S-methyltransferase activity as units per litre of whole-blood overcomes misleading high results in patients with anaemia

Annals of Clinical Biochemistry

Volumn 47, Issue 5, 2010, Pages 408-414

  Barlow, N L ^a   Graham, V ^a   Berg, J D ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; THIOPURINE METHYLTRANSFERASE;

ANEMIA; ARTICLE; BLOOD; ENZYME ACTIVITY; ENZYME ASSAY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; PHENOTYPE; PRIORITY JOURNAL; REFERENCE VALUE;

ANEMIA; BLOOD CHEMICAL ANALYSIS; FALSE POSITIVE REACTIONS; GENOTYPE; HEMOGLOBINS; HUMANS; METHYLTRANSFERASES; PHENOTYPE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 77957673685     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2010.010058     Document Type: Article

References (41)

1. Seidman EG. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. Rev Gastroenterol Dis 2003;3:S30-8
2. Anstey AV, Wakelin S, Reynolds NJ. Guidelines for prescribing azathioprine in dermatology. Br J Dermatol 2004;151:1123-32
3. Vora A, Mitchell CD, Lennard L, et al. Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. Lancet 2006;368:1339-48 (Pubitemid 44528747)
4. Thervet E, Anglicheau D, Toledano N, et al. Long-term results of TPMT activity monitoring in azathioprine-treated renal allograft recipients. J Am Soc Nephrol 2001;12:170-6 (Pubitemid 32056803)
5. Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol 2004;2:731-43
6. Anstey A, Lennard L, Mayou SC, Kirby JD. Pancytopenia related to azathioprine - an enzyme deficiency caused by a common genetic polymorphism. J R Soc Med 1992;85:752-6
7. Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000;118:705-13 (Pubitemid 30171620)
8. Lennard L, Rees CA, Lilleyman JS, Maddocks JL. Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia. Br J Clin Pharmacol 1983;16:359-63 (Pubitemid 13015758)
9. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980;32:651-62
10. Fargher EA, Tricker K, Newman W, et al. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription. J Clin Pharmacol Ther 2007;32:187-95 (Pubitemid 46449703)
11. Ford L, Berg JD. Thiopurine s-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come. J Clin Pathol 2010;63:288-95
12. Holme SA, Duley JA, Sanderson J, Routledge PA, Anstey AV. Erythrocyte thiopurine methyl transferase assessment prior to azathioprine use in the UK. Q J Med 2002;95:439-44 (Pubitemid 34814662)
13. Richard VS, Al-Ismail D, Salamat A. Should we test TPMT enzyme levels before starting azathioprine? Hematology 2007;12:359-60
14. Editorial: TPMT testing before azathioprine therapy? Drug Ther Bull 2009;47:9-12
15. Relling MV, Hancock ML, Rivera GK, et al. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine s-methyltransferase gene locus. J Natl Cancer Inst 1999;91:2002-8
16. Clunie G, Lennard L. Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine. Rheumatology 2004;43:13-18 (Pubitemid 38088361)
17. Sanderson J, Ansari A, Marinaki T, Duley J. Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy? Ann Clin Biochem 2004;41:294-302
18. Yates CR, Krynetski EY, Loennechen T, et al. Molecular diagnosis of thiopurine S-methyl transferase deficiency. Genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997;126:608-14
19. Gardiner SJ, Gearry RB, Barclay ML, Begg EJ. Two cases of thiopurine methyltransferase (TPMT) deficiency - a lucky save and a near miss with azathioprine. Br J Clin Pharmacol 2006;62:473-6
20. Kaskas BA, Louis E, Hindorf U, et al. Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine. Gut 2003;52:140-2 (Pubitemid 36020781)
21. Lennard L, Lewis IJ, Michelagnoli M, Lilleyman JS. Thiopurine methyltransferase deficiency in childhood lymphoblastic leukaemia: 6-mercaptopurine dosage strategies. Med Pediatr Oncol 1997;29:252-5 (Pubitemid 27329123)
22. Ansari A, Hassan C, Duley J, et al. Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease. Aliment Pharmacol Ther 2002;16:1743-50
23. Cuffari C, Dassopoulos T, Turnbough L, Thompson RE, Bayless TM. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease. Clin Gastroenterol Hepatol 2004;2:410-7 (Pubitemid 38561239)
24. Gearry RB, Barclay ML, Roberts RL, et al. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice. Intern Med J 2005;35:580-5
25. Gardiner SJ, Gearry RB, Burt MJ, Ding SL, Barclay ML. Severe hepatotoxicity with high 6-methylmercaptopurine nucleotide concentrations after thiopurine dose escalation due to low 6-thioguanine nucleotides. Eur J Gastroenterol Hepatol 2008;20:1238-42
26. Woodson LC, Dunnette JH, Weinshilboum RM. Pharmacogenetics of human thiopurine methyltransferase: kidney-erythrocyte correlation and immunotitration studies. J Pharmacol Exp Ther 1982;222:174-81
27. Szumlanski CL, Honchel R, Scott MC, et al. Human liver thiopurine s-methyltransferase pharmacogenetics: biochemical properties, liver-erthrocyte correlation and presence of isoenzymes. Pharmacogenetics 1992;2:148-59
28. Ford LT, Cooper SC, Lewis MJV, Berg JD. Reference intervals for thiopurine S-methyltransferase activity in red blood cells using 6-thioguanine as substrate and a rapid non-extraction liquid chromatographic technique. Ann Clin Biochem 2004;41:303-8
29. Sies C, Florkowski C, George P, et al. Measurement of thiopurine methyl transferase activity guides dose-initiation and prevents toxicity from azathioprine. N Z Med J 2005;118:1324-8
30. Ford L, Graham V, Berg J. Whole-blood thiopurine S-methyltransferase activity with genotype concordance: a new, simplified phenotyping assay. Ann Clin Biochem 2006;43:354-60 (Pubitemid 44526533)
31. Lennard L, Chew TS, Lilleyman JS. Human thiopurine methyltransferase activity varies with red blood cell age. Br J Clin Pharmacol 2001;52:539-46
32. Brouwer C, De Abreu RA, Keizer-Garritsen JJ, et al. Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects. Eur J Cancer 2005;41:613-23 (Pubitemid 40292742)
33. See http://www.tpmtassay.com/Document/TPMTImmunoassayUserGuidev2.0.pdf (last checked 16 October 2009)
34. Collie-Duguid ES, Pritchard SC, Powrie RH, et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 1999;9:37-42
35. Cooper SC, Ford LT, Berg JD, Lewis MJ. Ethnic variation of thiopurine S-methyltransferase activity; a large, prospective population study. Pharmacogenomics 2008;9:303-9
36. Roberts RL, Barclay ML, Gearry RB, Kennedy MA. A multiplexed allele-specific polymerase chain reaction assay for the detection of common thiopurine s-methyltransferase (TPMT) mutations. Clin Chim Acta 2004;341:49-53
37. Lennard L, Chew TS, Lileyman JS. Human thiopurine methyltransferase activity varies with red blood cell age. Br J Clin Pharmacol 2001;52:539-46
38. Ford L, Kampanis P, Berg J. Thiopurine S-methyltransferase genotype-phenotype concordance: used as a quality assurance tool to help control the phenotype assay. Ann Clin Biochem 2009;46:152-4
39. Ford L, Prout C, Gaffney D, Berg J. Whose TPMT activity is it anyway? Ann Clin Biochem 2004;41:498-500
40. Compagni A, Bartoli S, Buehrlen B, Fattore G, Ibarreta D, de Mesa EG. Avoiding adverse drug reactions by pharmacogenetic testing: a systematic review of the economic evidence in the case of TPMT and AZA-induced side effects. Int J Technol Assess Health Care 2008;24:294-302 (Pubitemid 351950165)
41. Payne K, Newman WG, Gurwitz D, Ibarreta D, Phillips KA. TPMT testing in azathioprine: a 'cost-effective use of healthcare resources'? Person Med 2009;6:103-13